International union of pharmacology. X. Recommendation for nomenclature of α1-adrenoceptors: Consensus update

Pharmacological Reviews

Volumn 47, Issue 2, 1995, Pages 267-270

  Hieble, J P ^a   Bylund, D B ^a   Clarke, D E ^a   Eikenburg, D C ^a   Langer, S Z ^a   Lefkowitz, R J ^a   Minneman, K P ^a   Ruffolo Jr , R R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 4 (4 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID [3 (4,4 DIPHENYL 1 PIPERIDINYL)PROPYL]AMIDE METHYL ESTER; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 BROMO 7 CHLORO 3,4,5,6 TETRAHYDRO 4 METHYLFURO[4,3,2 EF][3]BENZAZEPINE; 5 [3 (4,4 DIPHENYL 1 PIPERIDINYL)PROPYLCARBAMOYL] 1,4 DIHYDRO 2,6 DIMETHYL 4 (4 NITROPHENYL) 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA ETHYL 3,4,5 TRIMETHOXY ALPHA [3 [[2 (2 METHOXYPHENOXY)ETHYL]AMINO]PROPYL]BENZENEACETONITRILE FUMARATE; CALCIUM CHANNEL BLOCKING AGENT; CHLOROETHYLCLONIDINE; INDORAMIN; NIGULDIPINE; NORADRENALIN; OXYMETAZOLINE; PRAZOSIN; RECEPTOR SUBTYPE; SKF 105854; UNCLASSIFIED DRUG;

HUMAN; LIGAND BINDING; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMAL; AORTA; HUMAN; INTERNATIONAL COOPERATION; KIDNEY; PHARMACOLOGY; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; SOCIETIES, PHARMACEUTICAL; SPLEEN; TERMINOLOGY;

EID: 0029072209     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)